Pharmafile Logo
Pharmafocus logo
Advanced Search

UK app launched for people living with glaucoma

April 1, 2022
Medical Communications

Santen UK has launched a new app for people living with glaucoma, in partnership with Glaucoma UK, the leading charity …

News

New research finds patient satisfaction with GP services has dropped since pre-pandemic

March 31, 2022

GP leaders have said that it is ‘unsurprising’ that more people are dissatisfied with the NHS than are satisfied, and …

News

FDA approval of Cabenuva for adolescents living with HIV

March 31, 2022
Business Services

ViiV Healthcare, the global specialist HIV company, today announced the FDA approval of Cabenuva (cabotegravir, rilpivirine), for the treatment of …

News

Carteyva receives IND approval for clinical trial in second-line large b-cell lymphoma

March 31, 2022
Business Services

An investigational new drug (IND) clearance from the National Medical Products Administration (NMPA) of China, for a pivotal clinical trial …

News

250,000 with diabetes to benefit from real time information after updated NICE recommendations

March 31, 2022
Business Services

Over 250,000 people living with type 1 diabetes are set to be offered new technology to help them manage their …

News

Kesimpta-treated adults with multiple sclerosis not at risk of severe COVID-19

March 30, 2022
Business Services

The peer-reviewed journal Neurology and Therapy has published new data on COVID-19 infections in people living with remitting multiple sclerosis …

News

Carthera’s SonoCloud demonstrates potential in Alzheimer’s patients

March 30, 2022
Business Services

Carthera has announced the publication of results in the Alzheimer’s Research & Therapy Journal, from an investigator-sponsored trial evaluating the …

News

Iktos announces a collaboration with Ono for new drug design

March 30, 2022
Research and Development

Iktos, a company specialised in AI for new drug design today announced a collaboration agreement with Ono Pharmaceuticals, on innovative …

News

$24 million in grants to help end HIV epidemic across the globe

March 30, 2022
Research and Development

Gilead Sciences announced $24 million in grants to help reduce health disparities, improve access to quality healthcare, advance medical education, …

News

Margaret Keegan joins RQM+ as new CEO

March 29, 2022

RQM+, a world leading provider of regulatory, clinical and quality solutions to the MedTech industry, announced the appointment of life …

Appointment

Injecting real-world data into every day clinical trials – RWE and RWD

March 29, 2022

The past two years have seen unprecedented pressure on healthcare systems, its workers, and clinical research as a whole. COVID-19 …

Feature

Preparation Preconditions: What measures are needed to combat another pandemic?

March 29, 2022

Could we have foreseen the damage caused by the COVID-19 pandemic? This is a central question that has plagued biopharma …

Feature

CHMP recommends approval of Janssen’s first CAR-T therapy

March 29, 2022
Manufacturing and Production

Johnson & Johnson have announced the CHMP recommendation of marketing authorisation of ciltacabtagene autoleucel (cilta-cel) for the treatment of adults …

News

Telix granted FDA orphan drug designation for bone marrow conditioning treatment

March 29, 2022
Manufacturing and Production

The FDA has granted Orphan Drug Designation (ODD) for TLX66, for conditioning treatment prior to hematopoietic stem cell transplant (HSCT). …

News

Japan: drug approved for treatment of life-threatening bleeding

March 29, 2022
Manufacturing and Production

AstraZeneca has announced that Ondexxya has become the first approved medicine in Japan to reverse the anticoagulant effect of Factor …

News

BIMZELX effective for moderate to severe plaque psoriasis treatment

March 29, 2022
Manufacturing and Production

UCB has revealed results from its Phase III/IIIb trials of BIMZELX (bimekizumab) for the treatment of adults with moderate to …

News

NICE does not recommend icosapent ethyl for prevention of cardiovascular events

March 28, 2022
Sales and Marketing

NICE has published further draft guidance for public consultation which does not recommend VAZKEPA (icosapent ethyl) for reducing the risk …

News

FDA approve oral solution for rare childhood epilepsy

March 28, 2022
Sales and Marketing

UCB has announced that FINTEPLA® (fenfluramine) oral solution CIV has been approved by the FDA for the treatment of seizures …

News

EMA review first novel gene therapy candidate for haemophilia B

March 28, 2022
Sales and Marketing

CSL Behring has today announced that the EMA has accepted the Marketing Authorising Application for etranacogene dezaparvovec (EtranaDez), under its …

News

Pregnant women to receive life-saving pre-eclampsia check on NHS

March 28, 2022
Sales and Marketing

A life-saving blood test that can help diagnose suspected preterm pre-eclampsia has been recommended by NICE, and this is to …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026